new_0222_0442|KLDO|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0442|KLDO|1|Kaleido Biosciences Inc Total Current Assets (Quarterly) (USD)|Kaleido Biosciences Inc Cash and Short Term Investments (Quarterly) (USD)|Kaleido Biosciences Inc Inventories (Quarterly) (USD)|Kaleido Biosciences Inc Net PP&E (Quarterly) (USD)|Kaleido Biosciences Inc Goodwill and Intangibles (Quarterly) (USD)|Kaleido Biosciences Inc Total Liabilities (Quarterly) (USD)|Kaleido Biosciences Inc Total Current Liabilities (Quarterly) (USD)|Kaleido Biosciences Inc Total Long Term Liabilities (Quarterly) (USD)|Kaleido Biosciences Inc Total Deposits (Quarterly) (USD)|Kaleido Biosciences Inc Book Value (Quarterly) (USD)|Kaleido Biosciences Inc Retained Earnings (Quarterly) (USD)|Kaleido Biosciences Inc Treasury Stock (Quarterly) (USD)|Kaleido Biosciences Inc EV to Revenues|Kaleido Biosciences Inc EV to Earnings|Kaleido Biosciences Inc EV to Free Cash Flow|Kaleido Biosciences Inc EV to Assets (Quarterly)|Kaleido Biosciences Inc PS Ratio|Kaleido Biosciences Inc PE Ratio|Kaleido Biosciences Inc Price to Book Value|Kaleido Biosciences Inc PEG Ratio|Kaleido Biosciences Inc Debt to Equity Ratio|Kaleido Biosciences Inc Dividend Yield|Kaleido Biosciences Inc Shareholder Yield (TTM)|Kaleido Biosciences Inc Percent of Shares Outstanding Short|Kaleido Biosciences Inc Total Receivables (Quarterly) (USD)|Kaleido Biosciences Inc Total Payables (Quarterly) (USD)|Kaleido Biosciences Inc Total Capital Stock (Quarterly) (USD)|Kaleido Biosciences Inc Return on Invested Capital|Kaleido Biosciences Inc Quality Ratio Score|Kaleido Biosciences Inc Momentum Score|Kaleido Biosciences Inc Beta (1Y)|Kaleido Biosciences Inc Sustainable Growth Rate (TTM)|Kaleido Biosciences Inc Institutional Investor Ownership Percentage|Kaleido Biosciences Inc Average Diluted Shares Outstanding (Quarterly)|Kaleido Biosciences Inc Total Employees (Annual)|Kaleido Biosciences Inc EPS Diluted (Quarterly) (USD)|Kaleido Biosciences Inc Shares Outstanding|Kaleido Biosciences Inc Repurchase of Capital Stock (Quarterly) (USD)|Kaleido Biosciences Inc Ordinary Shares Number (Quarterly)|Kaleido Biosciences Inc Payout Ratio|Kaleido Biosciences Inc Quick Ratio (Quarterly)|Kaleido Biosciences Inc Normalized Diluted EPS (Quarterly) (USD)|Kaleido Biosciences Inc Stock Buybacks (Quarterly) (USD)|Kaleido Biosciences Inc Effective Tax Rate (TTM)|Kaleido Biosciences Inc Return on Equity|Kaleido Biosciences Inc Net Income (TTM) (USD)|Kaleido Biosciences Inc Revenue (TTM) (USD)|Kaleido Biosciences Inc Dividend Per Share (Quarterly) (USD)|Kaleido Biosciences Inc Revenue (Quarterly) (USD)|Kaleido Biosciences Inc Gross Profit (Quarterly) (USD)|Kaleido Biosciences Inc SG&A Expense (Quarterly) (USD)|Kaleido Biosciences Inc Pre-Tax Income (Quarterly) (USD)|Kaleido Biosciences Inc Net Income (Quarterly) (USD)|Kaleido Biosciences Inc Net Interest Income (Quarterly) (USD)|Kaleido Biosciences Inc Price (USD)|Kaleido Biosciences Inc Total Return Price (USD)|Kaleido Biosciences Inc Enterprise Value (USD)|Kaleido Biosciences Inc 30-Day Average Daily Volume|Kaleido Biosciences Inc 1 Year Price Returns (Daily)||
new_0222_0442|KLDO|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0442|KLDO|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|yearly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0442|KLDO|5|105.307692308|105.307692308||105.307692308||105.307692308|105.307692308|105.307692308||105.307692308|105.307692308||1.44196428571|91.5|6.95512820513|91.4|1.44||6.98013245033||91.4|1.44666666667|91.5|15.2571428571|136.5|105.307692308|105.307692308|91.5||31.9523809524|30.5217391304|91.5||91.2666666667|365.5|91.2666666667|32.6666666667||105.307692308|91.5|91.4|91.2666666667|91.3571428571||91.5|91.3333333333|91.5||91.4||91.2666666667|91.2666666667|91.2666666667|91.2666666667|6.87341772152|6.87341772152|6.95512820513|6.96|1.44578313253||
new_0222_0442|KLDO|6|13|13||13||13|13|13||13|13||224|2|156|5|225||151||5|750|2|70|4|13|13|2||21|23|2||15|2|15|30||13|2|5|15|14||2|12|2||5||15|15|15|15|158|158|156|150|498||
new_0222_0442|KLDO|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0442|KLDO|201712|28.551|28.456||1.975||74.426|3.854|70.572||-43.679|-44.484||||||||||||||0.045|0.864|0.005|||||||22.4176||-0.4529|||29.3948|||-0.4529|||||||||2.46|-10.152|-10.152|-0.207|||||||
new_0222_0442|KLDO|201803||||||||||||||||||||||||||||||||||22.4176||-0.48||||||-0.4644|||||||||2.67|-10.76|-10.76|-0.179|||||||
new_0222_0442|KLDO|201806||||||||||||||||||||||||||||||||||22.4176||-0.5508||||||-0.5509|||||||||3.21|-12.348|-12.348|0.018|||||||
new_0222_0442|KLDO|201809|93.115|92.55||3.35||178.225|7.938|170.287||-78.022|-84.998||||||||||||||0.034|1.947|0.011|||||||22.4176||-0.7764|||29.3948|||-0.7739||||-50.666|||||7.144|-17.406|-17.406|0.132|||||||
new_0222_0442|KLDO|201812|76.243|76.086||4.693||181.569|11.301|170.268||-96.244|-106.228||||-7.3081|||||||||||3.442|0.006|||||||29.3948|118|-0.7222|29.6329||29.3948|||-0.7048||||-61.744|||||5.597|-21.23|-21.23|0.142|14.23|14.23|360.4212||||
new_0222_0442|KLDO|201903|123.983|121.34||5.103||24.132|8.849|15.283||107.136|-126.447||||-7.1759||||4.0061|||||0.9967||3.575|0.03|||||||12.964||-1.56|29.5795||29.5795|||-1.5794|-69.443|||-71.203|||||5.433|-20.219|-20.219|0.149|14.01|14.01|353.9019|75332.8667||14.94|16.29
new_0222_0442|KLDO|201906|101.916|99.958||5.896||25.371|11.648|13.723||84.626|-151.086||||-3.6036||||3.5167|||||1.8051||4.046|0.03|||||||29.6672||-0.83|29.7868||29.7869|||-0.83|1.021|||-83.494|||||6.181|-24.639|-24.639|0.324|12.64|12.64|228.8406|50485.7667||7.45|9.09
new_0222_0442|KLDO|201909|83.214|81.272||5.811||25.172|10.256|14.916||66.04|-173.047||||-1.8561||||3.0352|||||3.6179||1.657|0.03|||||||29.8562||-0.74|30.0557||30.0557|||-0.74|0.661|||-88.049|||||5.93|-21.961|-21.961|0.171|8.61|8.61|135.66|86252.6||6.28|8.37
new_0222_0442|KLDO|201912|73.279|71.241||6.742||33.423|10.377|23.046||48.883|-192.559||||-1.277||||3.094|||||6.037||2.016|0.03||||-0.47|||30.14|91|-0.65|30.1278||30.1278|||-0.6308||||-86.331|||||4.884|-19.512|-19.512|0.073|5.02|5.02|99.541|186829.7|-58.0464|8.31|6.72
new_0222_0442|KLDO|202003|57.469|53.804||7.063||33.198|9.304|23.894||33.621|-212.11||||-1.6779||||4.045|||||7.5927||1.224|0.03|||2|-0.4576|||30.3333||-0.64|30.4635||30.4635|||-0.64||||-85.663|||||5.917|-19.551|-19.551|-0.495|6.15|6.15|133.194|135440.1|-57.5862|6.75|7.78
new_0222_0442|KLDO|202006|77.235|71.032||7.583||35.657|11.498|24.159||51.322|-231.032||||-3.003|2.4411|||5.1187||0.4024|||6.4249||3.544|0.035|||2|0.481|||31.8807||-0.59|35.3566||35.3566||6.1778|-0.59|-33.182|||-79.946|||0.25||5.559|-18.922|-18.922|-0.653|7.43|7.43|212.3215|208968.8333|-35.9483|6.03|8.12
new_0222_0442|KLDO|202009|62.432|54.532||8.552||37.244|13.998|23.246||35.901|-254.163||||-4.4106|4.9618|||7.0578||0.5802|||7.6861||3.835|0.035|||3|-0.331|||35.5541||-0.65|35.8295||35.8295||3.8957|-0.65|-1.142|||-81.116|||0.482||7.201|-23.131|-23.131|-0.692|10.19|10.19|311.8419|340960.6|47.012|6.625|7.18
new_0222_0442|KLDO|202012|48.721|46.222||8.462||38.848|16.659|22.189||20.496|-274.179||||-4.2543|5.099|||9.2609||1.025|||9.2015||5.389|0.036|||4|0.4363|||35.9841|82|-0.56|36.0228||36.0228||2.7746|-0.56|-3.432|||-81.62|||0.243||5.205|-20.016|-20.016|-0.713|9.24|9.24|298.7706|124921.8333|81.2749|12.62|9.76
new_0222_0442|KLDO|202103|95.032|92.362||7.833||33.252|12.873|20.379||71.774|-297.221||214.5786|-3.2069|-5.0256|2.5988|227.8307||17.3008||0.2953||-31.3339|6.6177||2.412|0.042|-129.3598||7|-1.1727|-199.6842||39.6926||-0.58|42.4832||42.4832||7.1749|-0.58|-69.978||-199.6842|-85.111|1.272||0.297||5.46|-23.042|-23.042|-0.688|7.26|7.26|329.3848|250760.9|31.7073|7.65|6.76
new_0222_0442|KLDO|202106|74.603|71.979||7.526||34.024|12.269|21.755||50.266|-321.11||215.812|-2.9541|-3.7692|3.1569|231.9635||4.6977||0.4246||-23.5479|8.0337||2.695|0.043|-134.5307||2|-1.5108|-196.0271||42.5386||-0.56|42.5714||42.5714||5.8667|-0.56|0.053||-196.0271|-90.078|1.233||0.211||5.785|-23.889|-23.889|-0.681|7.59|7.59|266.0033|374973.9667|0.1346|5.5|6.14
new_0222_0442|KLDO|202109|58.304|55.657||7.339||38.604|19.261|19.343||29.2|-344.195||231.984|-2.2031|-2.7326|2.9253|256.7043||7.9619||0.7368||-31.6273|6.1691||3.559|0.043|-143.5798||3|1.8948|-216.8014||42.5776||-0.54|42.5801||42.5801||2.8896|-0.54|||-216.8014|-90.032|0.855||0.104||5.106|-23.085|-23.085|-0.692|5.44|5.44|198.3463|118308.4|-50.6775|4.27|3.59
new_0222_0442|KLDO|202112|||||||||||||79.1341||-1.1551||112.3669||4.0406|||||5.023||||||2|-2.6313||||||||||||||||||||||||2.58|2.58|83.8455|160160.4667|-73.7363|2.23|1.57